ImmunoPrecise Antibodies (IPA) News Today → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free IPA Stock Alerts $1.15 -0.05 (-4.17%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 26, 2024 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (IPA)March 28, 2024 | finance.yahoo.comInterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 28, 2024 | businesswire.comInterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 20, 2024 | businesswire.comIPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI DevelopmentsMarch 15, 2024 | msn.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2024 Earnings Call TranscriptMarch 14, 2024 | investorplace.comIPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024March 7, 2024 | finance.yahoo.comIPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 7, 2024 | businesswire.comIPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 4, 2024 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024February 10, 2024 | marketbeat.comImmunoPrecise Antibodies (NASDAQ:IPA) Shares Down 2.3% ImmunoPrecise Antibodies (NASDAQ:IPA) Trading Down 2.3%December 16, 2023 | markets.businessinsider.comBuy Rating on ImmunoPrecise Antibodies Reflects Strong Revenue Growth and Cost Management SuccessDecember 8, 2023 | finance.yahoo.comIPA Announces Closing of $1.265 Million Public Offering of Common SharesDecember 6, 2023 | benzinga.comWhy ImmunoPrecise Antibodies (IPA) Stock Is Down 20% TodayDecember 6, 2023 | investorplace.comWhy Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?December 6, 2023 | finance.yahoo.comIPA Announces Pricing of $1.1 Million Public Offering of Common SharesDecember 5, 2023 | investing.comAfter-hours movers: SentinelOne up on earnings, MongoDB sees 'sell the news' reactionDecember 5, 2023 | finance.yahoo.comIPA Announces Proposed Public Offering of Common SharesNovember 27, 2023 | businesswire.comImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release CallNovember 22, 2023 | finance.yahoo.comImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug DiscoveryNovember 20, 2023 | benzinga.comImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug DiscoveryOctober 25, 2023 | stockhouse.comIPA's Subsidiary, BioStrand, Provides an Update on LENSai(TM)October 25, 2023 | benzinga.comIPA's Subsidiary, BioStrand, Provides an Update on LENSai™October 25, 2023 | financialpost.comIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™October 20, 2023 | finance.yahoo.comOvercoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological DataOctober 20, 2023 | finance.yahoo.comHow ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody ResearchSeptember 19, 2023 | finance.yahoo.comImmunoPrecise Antibodies Announces CFO TransitionSeptember 18, 2023 | nasdaq.comHC Wainwright & Co. Reiterates ImmunoPrecise Antibodies (IPA) Buy RecommendationSeptember 18, 2023 | markets.businessinsider.comImmunoPrecise Antibodies (IPA) Receives a Buy from H.C. WainwrightSeptember 17, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call TranscriptSeptember 5, 2023 | finance.yahoo.comIPA Announces Board RefreshmentAugust 9, 2023 | finance.yahoo.comIPA Responds to 13D FilingJuly 7, 2023 | finance.yahoo.comImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023July 6, 2023 | msn.comImmunoPrecise Antibodies's Earnings OutlookJune 29, 2023 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.May 30, 2023 | finance.yahoo.comIPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems BiologyMay 17, 2023 | finance.yahoo.comIPA to Present at Jefferies Healthcare Conference 2023April 18, 2023 | benzinga.comTheStreetReports: Disruptive Technology Stocks in Focus – KAVL, SONM, PBTS, IPAMarch 30, 2023 | finance.yahoo.comImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with AstellasMarch 29, 2023 | stockhouse.comEuropean Patent Office to Grant BioKey's Patent Application for Foundational HYFT® TechnologyMarch 27, 2023 | finance.yahoo.comEuropean Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® TechnologyMarch 23, 2023 | finance.yahoo.comImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival RatesMarch 15, 2023 | finance.yahoo.comImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera BioMarch 7, 2023 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023December 22, 2022 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Rigel (RIGL), ImmunoPrecise Antibodies (IPA)December 8, 2022 | finance.yahoo.comIPA’s Subsidiary BioStrand Completes Integration of 20 Million Proprietary Structural HYFTs™ and Accelerates in Silico Drug Discovery DevelopmentsDecember 5, 2022 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022December 2, 2022 | marketbeat.comImmunoPrecise Antibodies (NASDAQ:IPA) Receives New Coverage from Analysts at HC WainwrightHC Wainwright assumed coverage on ImmunoPrecise Antibodies in a research note on Friday. They issued a "buy" rating on the stock.November 30, 2022 | finance.yahoo.comIPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer AntibodiesNovember 22, 2022 | seekingalpha.comImmunoPrecise Antibodies to delist from TSXVNovember 22, 2022 | finance.yahoo.comImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting from TSX Venture Exchange Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars. Click here to find out who they are. IPA Media Mentions By Week IPA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼1.430.55▲Average Medical News Sentiment IPA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼20▲IPA Articles Average Week Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Spruce Biosciences News Fortress Biotech News Viracta Therapeutics News BriaCell Therapeutics News Daré Bioscience News Acurx Pharmaceuticals News Marker Therapeutics News Apollomics News ProMIS Neurosciences News CASI Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
